❌

Normal view

Daily briefing: Safety review is big step towards the first FDA-approved CRISPR therapy

Nature, Published online: 30 October 2023; doi:10.1038/d41586-023-03409-4

The US Food and Drug Administration is examining the safety of a DNA-altering treatment for sickle-cell disease. Plus, encouraging results from a big trial of anti-dengue mosquitoes and how to successfully switch fields.
❌